Clinical efficacy and safety of secukinumab for psoriasis in a real-world setting in turkey.
CONCLUSION: Our results are in line with the efficacy and safety profiles of secukinumab in PsO reported previously. Dose escalation and the addition of concomitant medications may increase response rates.
PMID: 33074062 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Dermatology | Eating Disorders & Weight Management | Middle East Health | Obesity | Psoriasis | Skin | Study | Turkey Health